High-fidelity propionaldehyde functionalized Poly(ethylene glycol): Synthesis and applications
An economical and efficient approach for synthesizing high-fidelity PEGn-Alds through a substitution and oxidation process has been developed, particularly avoiding peroxidation and breakage of PEG main chains in the oxidation step, laying a foundation for synthesizing high-quality drugs and develop...
Gespeichert in:
Veröffentlicht in: | European polymer journal 2024-11, Vol.220, p.113489, Article 113489 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | An economical and efficient approach for synthesizing high-fidelity PEGn-Alds through a substitution and oxidation process has been developed, particularly avoiding peroxidation and breakage of PEG main chains in the oxidation step, laying a foundation for synthesizing high-quality drugs and developing novel therapeutics.
[Display omitted]
•Economical and efficient approach for synthesizing high-fidelity propionaldehyde functionalized poly(ethylene glycol).•Avoiding the problem of oxidation chain breakage in traditional oxidation methods.•Realize multifunctional and large-scale preparation of propionaldehyde functionalized poly(ethylene glycol).
An economical and efficient approach for synthesizing high-fidelity PEGn-Alds through a substitution and oxidation process has been developed, providing a new pathway for obtaining high-purity PEGn-Alds, particularly addressing the issue of peroxidation and breakage of PEG main chains in the oxidation step. The synthesis of a series of high-fidelity PEGn-Alds with different functional groups or topological structures further proves the versatility of this new method. Additionally, PEGn-Alds also exhibit good biocompatibility, and potential ability to modify peptides and self-assembly to micelles, this lays a foundation for synthesizing high-quality drugs and developing novel therapeutics. |
---|---|
ISSN: | 0014-3057 |
DOI: | 10.1016/j.eurpolymj.2024.113489 |